NCT05364762 2025-05-30
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
City of Hope Medical Center
Phase 2 Active not recruiting
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × itacitinib × Other hematologic neoplasm × Clear all